Increasing role of the WHO monographs on selected medicinal plants
Over the past two decades, there has been a tremendous increase in the use of herbal medicine; however, there is still a significant lack of research data in this field. Therefore since 1999, WHO has published three volumes of the WHO monographs on selected medicinal plants: volume 1 includes 28 monographs; volume 2 contains an additional 30 monographs; and volume 3 provides 31 monographs. Including the 28 new monographs published in this volume, a total of 118 monographs in four volumes are now available on the WHO web site (http://www.who.int/medicinedocs/ en/m/abstract/Js 14213e/).
Due to the diversity of medicinal plants and herbal medicines, it is difficult for WHO to continue to develop more monographs on commonly used medicinal plants. One of the objectives of WHO monographs is to provide a model that will support countries in developing their own national or regional monographs on medicinal plants or national formularies on herbal medicines. Experts can be trained through the process of developing country-specific or regional monographs, and national capacity in this field can thus be built up.
For example, at WHO’s regional training workshop on regulation of herbal medicines held for the WHO European Region, in September 2003, the participating national drug regulatory authorities of many of the Newly Independent States (NIS) submitted their request to WHO directly, for assistance in the development of monographs on medicinal plants commonly used in NIS.
In order to respond to their urgent need, WHO initiated a new project to develop a set of regional (NIS) monographs on commonly used medicinal plants, based on available scientific information relating to their safety, efficacy and quality, which will facilitate the creation of effective and practical regulatory and quality assurance measures on herbal medicines. WHO has been working with 15 national drug regulatory authorities interested in this publication in NIS, Countries of Central and Eastern Introduction
Europe (CCEE) and their neighbouring countries, in close collaboration with the WHO Regional office for Europe. The 13 new monographs on commonly used medicinal plants in NIS have been drafted based on the format of the WHO monographs by the experts in NIS and CCEE countries with the support of experts, national health authorities and NGOs within and also outside the NIS and CCEE countries. The WHO monographs on medicinal plants commonly used in NIS have been completed and will be published soon. Based on the NIS countries model, in the future, WHO would like to cooperate with more countries or regions to develop their monographs on commonly used medicinal plants.
Preparation of monographs for volume 4
Selection of medicinal plants
The selection of medicinal plants for inclusion in the WHO monographs is based on worldwide use. The medicinal plants selected must meet two major criteria: (1) they must be in common use in at least two WHO Regions; and (2) there must be sufficient scientific data available to satisfy the requirements of the various sections in the monograph format.
The recommended selection criteria discussed at the Third WHO Consultation on Selected Medicinal Plants (Ottawa, Canada, July 2001) were applied to the preparation of volume 4 of the WHO monographs.
Preparation
During the preparation of volume 4, more than 200 experts were involved in addition to members of WHO’s Expert Advisory Panel on Traditional Medicine, a significant expansion compared to the numbers involved in the previous three volumes. National drug regulatory authorities in 81 countries participated in the process, again a greater number than for the previous volumes. This global network of active players facilitated wider access to the available scientific references and information, in terms of both quality and quantity. This considerable level of support contributed greatly to the efficiency of the preparation process.
The Fourth WHO Consultation on Selected Medicinal Plants was held in Salcrno-Pacstum, Italy, in October 2005 to review and finalize the draft monographs. Thiity-four experts and drug regulatory authorities from WHO Member States participated (Annex 1). Following extensive discussion, 28 of the 32 draft monographs were adopted for inclusion.
[EBOOK] WHO monographs on selected medicinal plants (VOLUME 4), World Health Organization
Over the past two decades, there has been a tremendous increase in the use of herbal medicine; however, there is still a significant lack of research data in this field. Therefore since 1999, WHO has published three volumes of the WHO monographs on selected medicinal plants: volume 1 includes 28 monographs; volume 2 contains an additional 30 monographs; and volume 3 provides 31 monographs. Including the 28 new monographs published in this volume, a total of 118 monographs in four volumes are now available on the WHO web site (http://www.who.int/medicinedocs/ en/m/abstract/Js 14213e/).
Due to the diversity of medicinal plants and herbal medicines, it is difficult for WHO to continue to develop more monographs on commonly used medicinal plants. One of the objectives of WHO monographs is to provide a model that will support countries in developing their own national or regional monographs on medicinal plants or national formularies on herbal medicines. Experts can be trained through the process of developing country-specific or regional monographs, and national capacity in this field can thus be built up.
For example, at WHO’s regional training workshop on regulation of herbal medicines held for the WHO European Region, in September 2003, the participating national drug regulatory authorities of many of the Newly Independent States (NIS) submitted their request to WHO directly, for assistance in the development of monographs on medicinal plants commonly used in NIS.
In order to respond to their urgent need, WHO initiated a new project to develop a set of regional (NIS) monographs on commonly used medicinal plants, based on available scientific information relating to their safety, efficacy and quality, which will facilitate the creation of effective and practical regulatory and quality assurance measures on herbal medicines. WHO has been working with 15 national drug regulatory authorities interested in this publication in NIS, Countries of Central and Eastern Introduction
Europe (CCEE) and their neighbouring countries, in close collaboration with the WHO Regional office for Europe. The 13 new monographs on commonly used medicinal plants in NIS have been drafted based on the format of the WHO monographs by the experts in NIS and CCEE countries with the support of experts, national health authorities and NGOs within and also outside the NIS and CCEE countries. The WHO monographs on medicinal plants commonly used in NIS have been completed and will be published soon. Based on the NIS countries model, in the future, WHO would like to cooperate with more countries or regions to develop their monographs on commonly used medicinal plants.
Preparation of monographs for volume 4
Selection of medicinal plants
The selection of medicinal plants for inclusion in the WHO monographs is based on worldwide use. The medicinal plants selected must meet two major criteria: (1) they must be in common use in at least two WHO Regions; and (2) there must be sufficient scientific data available to satisfy the requirements of the various sections in the monograph format.
The recommended selection criteria discussed at the Third WHO Consultation on Selected Medicinal Plants (Ottawa, Canada, July 2001) were applied to the preparation of volume 4 of the WHO monographs.
Preparation
During the preparation of volume 4, more than 200 experts were involved in addition to members of WHO’s Expert Advisory Panel on Traditional Medicine, a significant expansion compared to the numbers involved in the previous three volumes. National drug regulatory authorities in 81 countries participated in the process, again a greater number than for the previous volumes. This global network of active players facilitated wider access to the available scientific references and information, in terms of both quality and quantity. This considerable level of support contributed greatly to the efficiency of the preparation process.
The Fourth WHO Consultation on Selected Medicinal Plants was held in Salcrno-Pacstum, Italy, in October 2005 to review and finalize the draft monographs. Thiity-four experts and drug regulatory authorities from WHO Member States participated (Annex 1). Following extensive discussion, 28 of the 32 draft monographs were adopted for inclusion.
[EBOOK] WHO monographs on selected medicinal plants (VOLUME 4), World Health Organization
Keyword: ebook, giáo trình, medicinal plants, WHO monographs on selected medicinal plants, cây thuốc, câu dược liệu, dược liệu, tuyển chọn cây thuốc, Chuyên khảo của WHO về cây thuốc được chọn
Không có nhận xét nào:
Đăng nhận xét
levantaihg@gmail.com